Mold Prompts Recall of 5,000 Vials of Johnson & Johnson's Schizophrenia Drug

Published: Sep 13, 2013

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Johnson & Johnson is voluntarily recalling one lot of schizophrenia drug Risperdal Consta after discovering mold during a routine testing process, a company spokeswoman said, the latest in a string of recalls over the past two years. Risperdal Consta is manufactured by Janssen Pharmaceuticals, a unit of Johnson & Johnson. The company is recalling the drug from wholesalers, distributors, pharmacies and healthcare providers.

Help employers find you! Check out all the jobs and post your resume.

Back to news